GlobeNewsWire
16 Nov 2025, 21:10 UTC · 43w ago
Verdict
Headline takes no side. We score QLGN +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 75% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Qualigen Therapeutics is pivoting its entire business model from biotechnology to a Web3-driven decentralized artificial intelligence (DeAI) platform.
So whatA complete strategic pivot into high-growth sectors like AI and Web3 typically triggers significant speculative volatility and valuation resets.
More positive than 91% of claims this week
Faraday Future is expected to become the company's majority and controlling shareholder with an estimated 55% to 63% equity ownership.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 76% of claims this week
The company will rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) effective November 20, 2025.
More positive than 53% of claims this week
The company will unveil its full strategic transformation plan and a three-year development roadmap on November 20.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
The company successfully passed stockholder proposals to rebrand and pivot its strategy toward AI and Web3.
More positive than 64% of ticker scores this week
Faraday Future is becoming the majority and controlling shareholder of a new AI/Web3 entity, expanding its strategic influence.
More positive than 77% of relationship scores this week
[a_to_b] Faraday Future is expected to become the majority and controlling shareholder of Qualigen Therapeutics with an estimated 55% direct equity ownership.
More positive than 34% of relationship scores this week
[mutual] The companies expect a reciprocal strategic enablement dynamic to accelerate innovation and ecosystem integration.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1h ago
+17.6%
Price agrees with the score
$3.21 vs $2.73 close before publication (Nov 14) · not market-adjusted
QLGN chart →
